Stock Markets January 28, 2026

British Land unveils £150m offer for Life Science REIT; board recommends deal

Proposed transaction values LABS at 42.8p a share as portfolio review highlights development delays and write-downs

By Sofia Navarro BLND
British Land unveils £150m offer for Life Science REIT; board recommends deal
BLND

British Land has tabled a £150 million bid for Life Science REIT that values the company at 42.8 pence per share. The offer, which mixes cash and new British Land shares, has been recommended by the LABS board and already has irrevocable acceptances covering 31.1% of shareholders. The portfolio under review includes a delayed Oxford development and a downgraded Cambourne asset.

Key Points

  • British Land has offered 2.4% stake in the enlarged group for LABS shareholders post-transaction and expected eligibility for British Land's final FY26 dividend.
  • The offer values LABS at 42.8p per share, split as 14.1p cash plus 0.07 new British Land shares, a 21% premium to the recent share price and 15% above the three-month VWAP.
  • LABS' portfolio is valued at 332.6 million with a rent roll of 26.5 million.

British Land has made a formal proposal to acquire Life Science REIT (LABS) in a deal worth approximately £150 million, according to company disclosures.

The offer equates to a per-share value of 42.8 pence for LABS. That figure is composed of 14.1 pence in cash plus 0.07 new British Land shares for each LABS share. On a comparison basis, the proposed price is 21% above LABS' most recent share price of 35.4 pence and 15% higher than its three-month volume-weighted average price of 37.3 pence.

The bid sits materially below LABS' EPRA Net Tangible Assets, representing a 26% discount to the EPRA NTA of 57.7 pence reported as of December 31.

Board support and shareholder position

LABS' board has recommended that shareholders accept the offer. Irrevocable acceptances have already been obtained from holders representing 31.1% of LABS' shares. Under the terms set out, following completion of the acquisition LABS shareholders would own around 2.4% of the enlarged British Land group. They are also expected to be eligible for British Land's final dividend for the 2026 financial year, subject to the usual conditions.

Portfolio metrics and asset-level issues

The LABS portfolio is stated to be valued at 3300 million, with a rent roll of 26.5 million.

The asset mix is compact, concentrated across five properties. One of these is a 27 million development in the Oxford Technology Park that is suffering delays tied to costly redesign work. The ongoing conversion of larger units into smaller units has resulted in weaker leasing performance for that project.

Another holding in Cambourne has been reclassified down to a secondary business park, with an associated write-down recorded by the manager. Both of these assets sit roughly 10 miles from the central cores of Oxford and Cambridge respectively.


Sector impact

  • Real estate investment trusts (REITs): consolidation in the specialist life-science property segment and potential balance-sheet adjustments.
  • Development and leasing markets: implications for lease-up prospects on schemes converting unit sizes, and for valuation of secondary business parks.
  • Regional office and business park markets around Oxford and Cambridge: localised asset performance may influence investment and leasing dynamics.

Risks

  • Development delays and expensive redesign work at the Oxford Technology Park development could hamper leasing inflows and project returns, affecting development market sentiment.
  • Reclassification and write-down of the Cambourne property to a secondary business park may weigh on valuations and returns for assets in similar regional markets.
  • The offer price is substantially below LABS' EPRA NTA, which introduces uncertainty over the valuation gap and potential future adjustments to NAV metrics in the specialist life-science property sector.

More from Stock Markets

European equities tick up as metals rebound; Publicis and earnings cycle take center stage Feb 3, 2026 UK Grocery Price Growth Slows to 4.0% as Own-Label Spending Hits Record Share Feb 3, 2026 Tokyo Shares Surge to Record High as Nikkei Climbs Nearly 4% Feb 3, 2026 Price Guarantee Helped Close Anta's $1.8 Billion Acquisition of Puma Stake Feb 3, 2026 Australian Shares Finish Higher as Gold, IT and Mining Stocks Lead Gains Feb 3, 2026